2
Views
1
CrossRef citations to date
0
Altmetric
PLASMAPHERESIS

Therapeutic plasmapheresis

“Bloodletting” makes a return

Pages 251-255 | Published online: 07 Jul 2016

References

  • Burton R. Anatomy of melancholy. 1601: pt 2. sec 4. memb 3
  • Plasma exchange. (Editorial) Lancet 1980: 2: 241–2
  • Cocchetto DM, Cook L, Cato AE, et al. Rationale and proposal for use of prostacyclin in thrombotic thrombocytopenic purpura therapy. Semin Thromb Hemostas 1981: 7(1): 43–51
  • Edson JR, McArthur JR, Branda RF, et al. Suecessful management of a subdural hematoma in a hemophiliac with an anti-factor VIII antibody. Blood 1973: 41: 113–22
  • Marder VJ, Nusbacher J, Anderson FW. One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura. Transfusion 1981: 21(3): 291–8
  • Robinson EA, Tovey D. Intensive plasma exchange in the management of severe Rh disease. Br J Haematol 1980: 45: 621
  • Bukowski RM, Hewlett JS, Reimer RR, et al. Therapy of thrombotic thrombocytopenic purpura: an overview. Semin Thromb Hemostas 1981: 7(1): 1–8
  • Weiner HL, Dawson DM. Plasmapheresis in multiple sclerosis: preliminary study. Neurology 1980: 30(10): 1029–33
  • Dau PC, Petajan JH. Johnson KP, et al. Plasmapheresis in multiple sclerosis: preliminary findings. Neurology 1980: 30(10): 1023–8
  • Newsom-Davis J, Wilson SG, Vincent A, et al. Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979: 1(8114): 464–8
  • Wells JV, Fudenberg HH. Paraproteinemias DM 1974 Feb: 1–45
  • Powles R, Smith C, Kohn J, et al. Methods of removing abnormal protein rapidly from patients with malignant paraproteinemias. Br Med J 1971: 3: 664–7
  • Lockwood CM, Pusey CD, Rees AJ, et al. Plasma exchange in the treatment of immune complex disease. Clin Immunol Allergy 1981: 1(2): 433–55
  • O'Reilly MJ, Talpos G, Roberts VC, et al. Controlled trial of plasma exchange in treatment of Raynaud's syndrome. Br Med J 1979: 1(6171): 1113–5
  • Dau PC, Kahaleh MB, Sagebiel RW. Plasmapheresis and immunosuppressive drug therapy in scleroderma. Arthritis Rheum 1981: 24(9): 1128–36
  • Wallace D, Goldfinger D, Lowe C, et al. A double-blind. controlled study of lymphoplasmapheresls versus sham apheresis in rheumatoid arthritis. N Engl J Med 1982: 306(23): 1406–10
  • Brubaker DB, Winkelstein A. Plasma exchange in rheumatoid vasculitis. Vox Sang 1981: 41(5–6): 295–301
  • Evans DT, Giles M, Home DJ, et al. Cerebral lupus erythematosus responding to plasmaphaeresis. Postgrad Med J 1981: 57(666): 247–51
  • McCullough JJ, Chopek M. Therapeutic plasma exchange. Lab Med 1981: 12(12): 745–53
  • Cohen PG. Circulatory access for extracorporal blood modification. Plasma Ther 1981: 2(4): 235–8
  • McLeod BC. Technical aspects of therapeutic plasmapheresis. Plasma Ther 1980: 1(1): 43–51
  • Martinez AM, Sechrest P. Hemolysis in normal donors during apheresis procedures. Plasma Ther 1981: 2(3): 153–4
  • Huestis DW, Thomas SF. Presently available plasmapheresis technics. In: Berkman EM, Unlas J, eds. Therapeutic hemapheresis. Washington. DC: American Association of Blood Banks, 1980: 1–11

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.